{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:38:55Z","timestamp":1789094335230,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/aog.0b013e318202ac23","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:21:31Z","timestamp":1292977291000},"page":"41-47","source":"Crossref","is-referenced-by-count":23,"title":["Effect of Injectable and Oral Contraceptives on Glucose and Insulin Levels"],"prefix":"10.1097","volume":"117","author":[{"given":"Abbey B.","family":"Berenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0029-7844(96)00194-9","article-title":"Experiences of injectable contraceptive users in an urban setting.","volume":"88","author":"Sangi-Haghpeykar","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who choose among levonorgestrel im-plant (Norplant), medroxyprogesterone acetate (depo-Provera), or the combined oral contraceptive pill as contraception.","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20\u03bcg oral contraceptive pills.","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.fertnstert.2006.05.024","article-title":"Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.","volume":"86","author":"Clark","year":"2006","journal-title":"Fertil Steril"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AOG.0b013e3181875b78","article-title":"Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density.","volume":"112","author":"Berenson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","article-title":"Effects of hormonal contraception on bone mineral density after 24 months of use.","volume":"103","author":"Berenson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.fertnstert.2004.04.064","article-title":"Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.","volume":"82","author":"Clark","year":"2004","journal-title":"Fertil Steril"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpag.2003.11.017","article-title":"Bone mineral density in adolescent females using depot medroxyprogesterone acetate.","volume":"17","author":"Lara-Torre","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.fertnstert.2007.10.070","article-title":"Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.","volume":"90","author":"Cromer","year":"2008","journal-title":"Fertil Steril"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","article-title":"Bone mineral density in women aged 25\u201335 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.","volume":"74","author":"Kaunitz","year":"2006","journal-title":"Contraception"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(91)90032-B","article-title":"Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.","volume":"44","author":"Fahmy","year":"1991","journal-title":"Contraception"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(85)90074-5","article-title":"Long-term effects of Depo-Provera on carbohydrate and lipid metabolism.","volume":"31","author":"Liew","year":"1985","journal-title":"Contraception"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0020-7292(85)90144-4","article-title":"The effects of long-acting injectable contraceptives on carbohydrate metabolism.","volume":"23","author":"Amatayakul","year":"1985","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(80)90007-4","article-title":"Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.","volume":"21","author":"Amatayakul","year":"1980","journal-title":"Contraception"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0022-4731(79)90070-0","article-title":"The effects of depo-provera on carbohydrate, lipids and vitamin metabolism.","volume":"11","author":"Amatayakul","year":"1979","journal-title":"J Steroid Biochem"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02627727","article-title":"Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives.","volume":"10","author":"Vermeulen","year":"1974","journal-title":"Diabetologia"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0020-7292(86)90086-X","article-title":"Metabolic effects of depot-medroxyprogesterone acetate in long-term users: a cross-sectional study.","volume":"24","author":"Virutamasen","year":"1986","journal-title":"Int J Gynaecol Obstet"},{"key":"R19-7-20210126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0010-7824(76)90088-3","article-title":"A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive.","volume":"14","author":"Tankeyoon","year":"1976","journal-title":"Contraception"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0010-7824(86)90101-0","article-title":"A comparative study of the metabolic effects of injectable and oral contraceptives.","volume":"33","author":"Liew","year":"1986","journal-title":"Contraception"},{"key":"R21-7-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0015-0282(16)42374-5","article-title":"Short-term effects of norethisterone oenanthate and medroxyprogesterone acetate on glucose, insulin, growth hormone, and lipids.","volume":"28","author":"Dhall","year":"1977","journal-title":"Fertil Steril"},{"key":"R22-7-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0010-7824(93)90141-S","article-title":"Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.","volume":"48","author":"Basdevant","year":"1993","journal-title":"Contraception"},{"key":"R23-7-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0010-7824(93)80142-I","article-title":"Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.","volume":"48","author":"Godsland","year":"1993","journal-title":"Contraception"},{"key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0010-7824(02)00415-8","article-title":"Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism.","volume":"66","author":"L\u00fcdicke","year":"2002","journal-title":"Contraception"},{"key":"R25-7-20210126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism.","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"R26-7-20210126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.contraception.2009.12.005","article-title":"An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol\/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.","volume":"81","author":"Winkler","year":"2010","journal-title":"Contraception"},{"key":"R27-7-20210126","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0002-9378(98)70291-1","article-title":"Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette.","volume":"179","author":"Berga","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R28-7-20210126","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0002-9378(98)70290-X","article-title":"An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group.","volume":"179","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R31-7-20210126","first-page":"685","article-title":"Effects of medroxyprogesterone acetate on carbohydrate metabolism.","volume":"43","author":"Tuttle","year":"1974","journal-title":"Obstet Gynecol"},{"key":"R32-7-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","article-title":"Free fatty acids and pathogenesis of type 2 diabetes mellitus.","volume":"11","author":"Bergman","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"R33-7-20210126","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0b013e318202ac23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T11:39:59Z","timestamp":1685878799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201101000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e318202ac23","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}